Advisors Asset Management Inc. bought a new position in abrdn Healthcare Investors (NYSE:HQH – Free Report) in the third quarter, according to the company in its most recent disclosure with the SEC. The fund bought 442,456 shares of the financial services provider’s stock, valued at approximately $9,243,000. Advisors Asset Management Inc. owned 0.77% of abrdn Healthcare Investors at the end of the most recent quarter.
Other hedge funds have also added to or reduced their stakes in the company. Wedbush Securities Inc. lifted its stake in shares of abrdn Healthcare Investors by 592.4% in the 2nd quarter. Wedbush Securities Inc. now owns 233,882 shares of the financial services provider’s stock worth $4,530,000 after purchasing an additional 200,104 shares during the period. Samalin Investment Counsel LLC grew its position in shares of abrdn Healthcare Investors by 17.9% during the 3rd quarter. Samalin Investment Counsel LLC now owns 182,351 shares of the financial services provider’s stock valued at $3,809,000 after acquiring an additional 27,735 shares during the period. NewEdge Advisors LLC increased its stake in shares of abrdn Healthcare Investors by 32.7% in the 1st quarter. NewEdge Advisors LLC now owns 151,738 shares of the financial services provider’s stock worth $2,699,000 after purchasing an additional 37,393 shares in the last quarter. Bank of America Corp DE grew its holdings in abrdn Healthcare Investors by 19.7% during the first quarter. Bank of America Corp DE now owns 225,672 shares of the financial services provider’s stock valued at $4,015,000 after purchasing an additional 37,177 shares during the period. Finally, Turner Financial Group Inc. purchased a new stake in abrdn Healthcare Investors in the second quarter worth about $388,000. 32.60% of the stock is currently owned by hedge funds and other institutional investors.
abrdn Healthcare Investors Price Performance
abrdn Healthcare Investors stock opened at $18.89 on Friday. abrdn Healthcare Investors has a 12-month low of $17.14 and a 12-month high of $24.85. The firm has a 50 day moving average of $20.65 and a 200 day moving average of $20.43.
abrdn Healthcare Investors Announces Dividend
abrdn Healthcare Investors Profile
abrdn Healthcare Investors is a closed-end investment company that seeks long-term capital appreciation by investing primarily in the securities of healthcare and life sciences businesses. Rather than providing healthcare services directly, the fund offers investors exposure to companies in the sector. Its investments may include businesses involved in pharmaceuticals, biotechnology, medical devices and other healthcare-related areas. The portfolio can include companies in the United States and other markets, and its holdings may change over time.
Read More
- Five stocks we like better than abrdn Healthcare Investors
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Receive News & Ratings for abrdn Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for abrdn Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.
